Top Markets
#1 Codatta Codatta +21.20%
#2 Saakuru Saakuru +13.57%
#3 Amiko Amiko +13.25%
#4 SuperVerse SuperVerse +12.39%
#5 Strategic Oil Supply Strategic Oil Supply +12.14%
#6 Bedrock Bedrock +11.78%
#7 Audiera Audiera +10.30%
#8 BitMEX BitMEX +10.14%
#9 Bless Bless +10.08%
#10 Ski Mask Dog Ski Mask Dog +9.94%
Coin of the day
Codatta Codatta
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Novartis AG Novartis AG

Novartis AG

NVS
Classifica tra le azioni #46
Novartis AG researches, develops, manufactures, and markets healthcare products... Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Prezzo delle azioni
$150.75
Capitalizzazione di mercato
$291.41B
Variazione (1 giorno)
1.44%
Variazione (1 anno)
40.17%
Paese
CH
Scambia Novartis AG (NVS)

Categoria

Healthcare
Storico dividendi per Novartis AG (NVS)
Novartis AG (simbolo azionario: NVS) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per Novartis AG (NVS) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
215.00%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
67.00%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
225.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
53.00%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
223.00%
US